Vu; Minh Diem

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vu; Minh Diem.The latest application filed is for "bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma".

Company Profile

10.6.17

Vu; Minh Diem - Wollerau CH
Vu; Minh Diem - Wolleran CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific Antibody Against Bcma And Cd3 And An Immunological Drug For Combined Use In Treating Multiple Myeloma App 20220017631 - Vu; Minh Diem ; et al.	2022-01-20
Bispecific Antibody Against Bcma And Cd3 And An Immunological Drug For Combined Use In Treating Multiple Myeloma App 20220002427 - Vu; Minh Diem ; et al.	2022-01-06
Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myeloma Grant 11,124,577 - Vu , et al. September 21, 2	2021-09-21
Method For The Selection Of Antibodies Against Bcma App 20210070873 - VU; Minh Diem ; et al.	2021-03-11
Bispecific Antibodies Against Cd3epsilon And Bcma For Use In Treatment Of Diseases App 20200385471 - Vu; Minh Diem ; et al.	2020-12-10
Method for the selection of antibodies against BCMA Grant 10,851,171 - Vu , et al. December 1, 2	2020-12-01
Monoclonal Antibodies Against Bcma App 20200283545 - Vu; Minh Diem ; et al.	2020-09-10
Bispecific Antibodies Against Cd3epsilon And Ror1 App 20200255521 - Kind Code	2020-08-13
Monoclonal antibodies against BCMA Grant 10,683,369 - Vu , et al.	2020-06-16
Monoclonal Antibodies Against Bcma App 20190352427 - Vu; Minh Diem ; et al.	2019-11-21
Bispecific Antibody Against Bcma And Cd3 And An Immunological Drug For Combined Use In Treating Multiple Myeloma App 20190263920 - Vu; Minh Diem ; et al.	2019-08-29
Bispecific antibodies against CD3 and BCMA Grant 10,253,104 - Vu , et al.	2019-04-09
Bispecific antibodies against CD3 and BCMA Grant 10,077,315 - Vu , et al. September 18, 2	2018-09-18
Method For The Selection Of Antibodies Against Bcma App 20180222991 - VU; Minh Diem ; et al.	2018-08-09
Method for the selection of antibodies against BCMA Grant 9,963,513 - Vu , et al. May 8, 2	2018-05-08
Bispecific Antibodies Against Cd3 Epsilon And Bcma For Use In Treatment Of Diseases App 20170327580 - Vu; Minh Diem ; et al.	2017-11-16
Bispecific Antibodies Against Cd3epsilon And Bcma App 20170327579 - VU; MINH DIEM ; et al.	2017-11-16
Bispecific Antibodies Against Cd3epsilon And Ror1 For Use In The Treatment Of Ovarian Cancer App 20170306044 - VU; MINH DIEM ; et al.	2017-10-26
Bispecific Antibodies Against Cd3epsilon And Ror1 App 20170306018 - VU; MINH DIEM ; et al.	2017-10-26
Bispecific Antibodies Against Cd3epsilon And Bcma App 20170306036 - VU; Minh Diem ; et al.	2017-10-26
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1 App 20160297881 - VU; Minh Diem ; et al.	2016-10-13
Bispecific Antibodies Against Cd3 And Bcma App 20150376287 - VU; Minh Diem ; et al.	2015-12-31
Method For The Selection Of Antibodies Against Bcma App 20150368351 - VU; Minh Diem ; et al.	2015-12-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.